Prof. Dr. Bernd Wollscheid
CEO
research
Adapt Pharma
Ireland
Biography
Prof. Dr. Bernd Wollscheid is Principal Investigator and Head of the Biomedical Proteomics Platform at the Department of Health Sciences and Technology of Swiss Federal Institute of Technology in Zurich, Switzerland. After studying chemistry in Freiburg and Boston he obtained his PhD in Molecular Immunology from the Max-Planck Institute for Immunobiology. His postdoctoral research took him to the Institute of Systems Biology in Seattle where he developed and applied chemoproteomic technologies to elucidate cell surface protein biology. Now at the Institute for Molecular Systems Biology at ETH Zurich he has developed a research programme focusing on a Systems Biology understanding of the cell surface as a cellular signaling gateway.
Research Interest
Molecular biology
